A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma

Figure 5

Identification of total genes having a correlation with survival in HCC using the top 10 reduced genes.(a) Patients with high expression of CYP3A4 and FCN3 showed a longer total survival as compared with those having low expressions of CYP3A4 and FCN3. (b) Univariate Cox regression analyses.

(a)

(b)